Investing

Thursday's Top Analysts Upgrades and Downgrades: Apple, Darden Restaurants, Peloton, Pfizer, Pioneer Natural Resources and More

Arco Platform Ltd. (NASDAQ: ARCE): Morgan Stanley raised the stock to Overweight from Equal Weight and has a $32.50 price target. The consensus target is up at $44.81, and the shares closed on Wednesday at $25.02.

Astec Industries (NASDAQ: ASTE): Stifel’s upgrade to Buy from Hold included a price target hike to $81 from $75. The posted consensus target is $82.33. The stock closed Wednesday at $65.95, down almost 15% for the day, after earnings came in way below expectations.

Cumulus Media Inc. (NASDAQ: CMLS): B. Riley Securities raised the stock to Buy from Neutral and has a $14 price target. The consensus target is $11.33. The stock closed trading on Wednesday at $9.00.

Darden Restaurants Inc. (NYSE: DRI): Cowen raised its Market Perform rating to Outperform and its price target went from $137 to $164. The consensus target is $155.76, and the last Wednesday trade came in at $142.23.

FMC Corp. (NYSE: FMC): Citigroup downgraded it to Neutral from Buy and has a $126 price target. The consensus target is higher at $132.21m and the closing price on Wednesday was $121.83 a share.

Maxeon Solar Technologies Ltd. (NASDAQ: MAXN): Though Raymond James upgraded the shares to Strong Buy from Outperform, the firm also lowered the price target to $33. The consensus target is $27.67, and the Wednesday close was at $15.43, which was down almost 8% for the day.


MercadoLibre Inc. (NASDAQ: MELI): Stifel raised the shares to Buy from Hold and has a $1,800 price target. The consensus target is even higher at $1,912.57, and Wednesday’s closing price was $1,530.54.

Mercury Systems Inc. (NASDAQ: MRCY): Jefferies upgraded the stock to Buy from Hold and has an $80 price target. The consensus target is up at $91.75m and the last trade on Wednesday came in at $57.69, and the stock pulled back almost 18% on the day. The company slightly beat estimates but announced very weak forward guidance.

Neurocrine Biosciences Inc. (NASDAQ: NBIX): Barclays upgraded the shares to Overweight from Equal Weight and has a $110 price target. The consensus target is $127.55, and the stock ended Wednesday’s trading session at $91.60 a share.

Paya Holdings Inc. (NASDAQ: PAYA): Credit Suisse started coverage with an Outperform rating and a $14 price target. The consensus target is higher $15.43, and the final Wednesday price was reported at $10.57.